Allogeneic Marrow Transplantation
- 1 January 1984
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 2 (1) , 27-38
- https://doi.org/10.3109/07357908409020284
Abstract
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.Keywords
This publication has 90 references indexed in Scilit:
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- Prevention and Therapy of Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- A Comparison of Marrow Transplantation with Chemotherapy for Children with Acute Lymphoblastic Leukemia in Second or Subsequent RemissionNew England Journal of Medicine, 1981
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Leukemia Relapse in Donor Cells after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1981
- Successful Bone-Marrow Transplantation for Infantile Malignant OsteopetrosisNew England Journal of Medicine, 1980
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionNew England Journal of Medicine, 1979
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979